iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/17530929
Recent developments in yeast aging - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 May 25;3(5):e84.
doi: 10.1371/journal.pgen.0030084.

Recent developments in yeast aging

Matt Kaeberlein  1 , Christopher R Burtner, Brian K Kennedy
Affiliations
Review

Recent developments in yeast aging

Matt Kaeberlein et al. PLoS Genet. .

Abstract

In the last decade, research into the molecular determinants of aging has progressed rapidly and much of this progress can be attributed to studies in invertebrate eukaryotic model organisms. Of these, single-celled yeast is the least complicated and most amenable to genetic and molecular manipulations. Supporting the use of this organism for aging research, increasing evidence has accumulated that a subset of pathways influencing longevity in yeast are conserved in other eukaryotes, including mammals. Here we briefly outline aging in yeast and describe recent findings that continue to keep this "simple" eukaryote at the forefront of aging research.

PubMed Disclaimer

Conflict of interest statement

Competing interests. BKK and MK have a pending patent application for technology for the identification of new aging genes. BKK has a minor stock holding in Elixir Pharmaceuticals.

Figures

Figure 1
Figure 1. Schematic for Yeast Replicative and Chronological Aging
(A) RLS in yeast is measured by the number of mitotic divisions that can arise from a single mother cell. Replicative viability is calculated as the mean number of daughters produced from mothers of a particular strain background before senescence. (B) CLS is measured by the length of time cells in a stationary culture can remain viable. Viability is calculated by the fraction of the culture able to reenter the cell cycle after an extended state of quiescence.
Figure 2
Figure 2. TOR Kinase Mediates Important Cellular Responses Implicated in Extended Longevity
During periods of nutrient availability, TOR kinase is activated, leading to G1 progression, translation initiation, increased ribosome biogenesis, and a suppression of autophagy and the stress response. When TOR is inactivated, either by DR or by the TOR inhibitor rapamycin, a cellular response is initiated that turns down protein translation and cell growth, and increases protein turnover and genes involved in the stress response. The conserved cellular regime that is the result of inactivated TOR kinase increases both replicative and chronological life span in yeast.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bitterman KJ, Medvedik O, Sinclair DA. Longevity regulation in Saccharomyces cerevisiae: Linking metabolism, genome stability, and heterochromatin. Microbiol. and Mol. Biol. Rev. 2003;67:376–399. - PMC - PubMed
    1. Jazwinski SM. Longevity, genes, and aging: A view provided by a genetic model system. Exp Gerontol. 1999;34:1–6. - PubMed
    1. Kaeberlein M. Longevity and aging in the budding yeast. In: Conn PM, editor. Handbook of models for human aging. Boston: Elvesier Press; 2006. pp. 109–120.
    1. Piper PW. Long-lived yeast as a model for ageing research. Yeast. 2006;23:215–226. - PubMed
    1. Mortimer RK, Johnston JR. Life span of individual yeast cells. Nature. 1959;183:1751–1752. - PubMed

Publication types

Substances

LinkOut - more resources